Gupta, Ravi
Henkel, Alexis
Forman, Howard P.
Ross, Joseph S.
Article History
First Online: 23 April 2018
Compliance with ethical standards
:
: Dr. Gupta is supported by the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). The analysis presented in this paper was completed while Ms. Henkel was an undergraduate at Yale University and was included in her unpublished senior thesis in 2017. She has since graduated from Yale University and is now employed by Morgan Stanley. In the past 36 months, Dr. Ross has received research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from Medtronic, Inc. and the Food and Drug Administration (FDA) to develop methods for postmarket surveillance of medical devices (U01FD004585), from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Blue Cross Blue Shield Association to better understand medical technology evaluation, from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting, from the Agency for Healthcare Research and Quality to examine community predictors of healthcare quality (R01HS022882), and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International and to establish the Collaboration for Research Integrity and Transparency (CRIT) at Yale. Dr. Forman has no conflicts of interest to disclose.